Photo: Microscope close up

Fluoxetine

Fluoxetine is a licensed medication in the treatment of depression. It's being tested in a phase 2 clinical trial called MS-SMART in people with secondary progressive MS.

Current phase of trial: Phase 2

Type of MS: Secondary progressive MS

Find out more about fluoxetine